Consuming dietary supplements containing curcumin has been shown to decrease the circulating levels of IAPP and GSK-3β. This finding introduces a new potential pathway by which curcumin might help to lower markers associated with insulin resistance, thereby possibly reducing the risk of T2D and AD. This evidence concerns the gene GSK3B and Alzheimer disease.